Global Oncologists Market Report 2023: An $84.77 Billion market by 2027
/PRNewswire/ -- The global oncologists market is expected to grow from $54.37 billion in 2022 to $60.36 billion in 2023 at a compound annual growth rate (CAGR)...
Stay updated with breaking news from Roche Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The global oncologists market is expected to grow from $54.37 billion in 2022 to $60.36 billion in 2023 at a compound annual growth rate (CAGR)...
/PRNewswire/ -- Baxter Planning, the leading provider of Service Parts Management technology, today announced that Roche Diagnostics Corporation, the North...
BioNTech is initiating a Phase 1/2 clinical trial of the mRNA-based mpox vaccine program, BNT166The Coalition for Epidemic Preparedness Innovations (CEPI) commits funding of up to $90 million for the
BioNTech is initiating a Phase 1/2 clinical trial of the mRNA-based mpox vaccine program, BNT166The Coalition for Epidemic Preparedness Innovations (CEPI) commits funding of up to $90 million for the development of
CARLSBAD, Calif.--(BUSINESS WIRE)--Sep 13, 2023--